Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple

Lucia Patriarca1, Silvia Torlone1, Fabiana Ferrari1

  • 1Department of Biotechnological and Applied Clinical Sciences, Radiology Unit, University of L'Aquila, Italy.

Insights

Tumefactive multiple sclerosis, a rare MS subtype, presents with large lesions mimicking tumors. Smaller lesions (<2cm) share similar imaging features and clinical outcomes with larger tumefactive plaques.

Area of Science:

  • Neurology
  • Neuroimmunology
  • Radiology

Background:

  • Tumefactive multiple sclerosis (MS) is a rare inflammatory demyelinating disease.
  • It is characterized by large, space-occupying lesions that can mimic neoplasms on imaging.
  • Atypical features include large plaque size (>2cm) with mass effect, edema, and ring enhancement on MRI.

Purpose of the Study:

  • To evaluate the prevalence of tumefactive plaques in a cohort of MS patients.
  • To analyze smaller lesions (0.5-2cm) with tumefactive characteristics.
  • To determine if lesion size impacts symptoms, disease progression, and prognosis.

Main Methods:

  • Retrospective review of 440 MS patients diagnosed between 2005 and 2014.
  • Analysis of radiographic features of lesions, focusing on size and MRI characteristics.
  • Comparison of clinical evolution and prognosis between smaller and larger lesions.

Main Results:

  • Lesions measuring 0.5-2cm exhibited similar MRI features to larger tumefactive plaques (>2cm).
  • Clinical evolution and prognosis were comparable between smaller and larger lesions.
  • The study suggests that lesion size alone may not be the sole determinant of disease behavior.

Conclusions:

  • Smaller lesions with tumefactive imaging characteristics appear to follow a similar clinical course to larger tumefactive plaques.
  • MRI features suggestive of aggressiveness may be present in lesions of varying sizes.
  • Further research is needed to refine prognostic criteria for tumefactive MS.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K
Inflammation01:38

Inflammation

Overview
63.6K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.7K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
714